Abstract : This study aims to assess the impact of the Covid-19 pandemic on fifteen leading Indian pharmaceutical companies listed on the Bombay Stock Exchange (BSE), chosen based on their highest market capitalization. Over a span of 26 months, encompassing 13 months pre-pandemic and 13 months post-pandemic, monthly stock market indices were analyzed. Utilizing descriptive statistics, percentage growth metrics, and graphical representations, the data reveals an amplified growth rate in the pharmaceutical sector post-Covid-19 compared to the pre-pandemic period. This research sheds light on the resilient performance and heightened growth experienced by the pharmaceutical industry in the aftermath of the global health crisis.
Keywords : Pharma, Stocks, Pandemic, India, Covid-19, Pharmaceutical, Stock Market
Cite : Srivastava, A., Gupta, S. K., Kumar, G., & Singh, Y. P., Rana (2024). Pandemic Impact On Indian Pharma Stocks: Unveiling Bse Evidence (1st ed., pp. 17-24). Noble Science Press. https://doi.org/10.52458/9788196897451.nsp.2024.eb.ch-03
References :
Aldieri, L., Bruno, B., Senatore, L., & Vinci, C. P. (2020). The future of pharmaceuticals industry within the triad: The role of knowledge spillovers in innovation process. Futures, 122, 102600.
Ayati, N., Saiyarsarai, P., & Nikfar, S. (2020). Short and long term impacts of COVID-19 on the pharmaceutical sector. DARU Journal of Pharmaceutical Sciences, 28(2), 799-805.
Baldi, S., & Vannoni, D. (2017). The impact of centralization on pharmaceutical procurement prices: the role of institutional quality and corruption. Regional Studies, 51(3), 426-438.
Barshikar, R. (2020). Covid 19–Impact and new normal for pharmaceutical industry (Part– I). Journal of Generic Medicines, 16(3), 112-119.
Belkhir, L., & Elmeligi, A. (2019). Carbon footprint of the global pharmaceutical industry and relative impact of its major players. Journal of Cleaner Production, 214, 185-194.
Bingöl, D., ?ener, ?., & Çevik, E. (2013). The effect of organizational culture on organizational image and identity: Evidence from a pharmaceutical company. Procedia- Social and Behavioral Sciences, 99, 222-229.
Briggs, K. (2021). Prescribing originality: investigating the impact of original knowledge on patent quality in the pharmaceutical sector. Journal of Entrepreneurship and Public Policy.
Carmelo Glaccotto et.al (2005) Giaccotto, C., Santerre, R. E., & Vernon, J. A. (2005). Drug prices and research and development investment behavior in the pharmaceutical industry. The Journal of Law and Economics, 48(1), 195-214.
Chittoor, R., Ray, S., Aulakh, P. S., & Sarkar, M. B. (2008). Strategic responses to institutional changes:‘Indigenous growth’model of the Indian pharmaceutical industry. Journal of International Management, 14(3), 252-269.
Chowdary, B. V., & George, D. (2012). Improvement of manufacturing operations at a pharmaceutical company: a lean manufacturing approach. Journal of Manufacturing Technology Management.
Dachyar, M., & Novita, G. (2016). Business Process Reengineering of Logistics System in Pharmaceutical Company. ARPN Journal of Engineering and Applied Sciences, 11(7), 4539-4546.
de Vrueh, R. L., & Crommelin, D. J. (2017). Reflections on the future of pharmaceutical public-private partnerships: from input to impact. Pharmaceutical research, 34(10), 1985- 1999.
G.Bharathi Kamath (2008) Kamath, G. B. (2008). Intellectual capital and corporate performance in Indian pharmaceutical industry. Journal of Intellectual Capital.
Gorge Mestre Ferandiz (2000) Ferrándiz, J. M. (1999). The impact of generic goods in the pharmaceutical industry. Health Economics, 8(7), 599-612.
Guler, I., & Nerkar, A. (2012). The impact of global and local cohesion on innovation in the pharmaceutical industry. Strategic Management Journal, 33(5), 535-549.
Gupta, K., Goel, S., & Bhatia, P. (2020). Intellectual capital and profitability: Evidence from Indian pharmaceutical sector. Vision, 24(2), 204-216.
Jadhav, N. V., Singh, N., Targhotra, M., & Chauhan, M. K. (2020). Impact of COVID-19 on Indian Pharmaceutical Industry and WayForward. Infectious disorders drug targets.
Kanavos, P., Schurer, W., & Vogler, S. (2011). The pharmaceutical distribution chain in the European Union: structure and impact on pharmaceutical prices.
Makowska, M. (2017). Polish physicians’ cooperation with the pharmaceutical industry and its potential impact on public health. PloS one, 12(9), e0184862.
Okereke, M., Ukor, N. A., Adebisi, Y. A., Ogunkola, I. O., Favour Iyagbaye, E., Adiela Owhor, G., & Lucero?Prisno III, D. E. (2021). Impact of COVID?19 on access to healthcare in low?and middle?income countries: current evidence and future recommendations. The International journal of health planning and management, 36(1), 13-17.
Patneedi, C. B., & Prasadu, K. D. (2015). Impact of pharmaceutical wastes on human life and environment. Rasayan Journal of Chemistry, 8(1), 67-70.
Pérez, C., Fernández, C., Méndez, V., Méndez, P., & Fernández, A. (2018). Evolution of GDP and its impact on the pharmaceutical sector of Ecuador (2007-2016). Journal of International Studies, 11(1).
Priyan, S., & Uthayakumar, R. (2014). Optimal inventory management strategies for pharmaceutical company and hospital supply chain in a fuzzy–stochastic environment. Operations Research for Health Care, 3(4), 177-190.
Sarkis, J., Schneider, J. L., Wilson, A., & Rosenbeck, J. M. (2010). Pharmaceutical companies and sustainability: an analysis of corporate reporting. Benchmarking: An International Journal.
Tyrawski,J.,&DeAndrea,D.C.(2015).Pharmaceutical companies and their drugs on social media: a content analysis of drug information on popular social media sites. Journal of medical Internet research, 17(6), e130.
